BRAF and cancer: Along this line, magnolol‐induced cell death was not observed in the BRAF/NRAS wild‐type melanoma cell line, D24 and the human immortalized keratinocyte cell line, HaCaT (Figure S1D) suggesting that the effect of magnolol at lower concentrations might be specific for BRAF/NRAS‐mutant cancer cells.